Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISATA THERAPEUTICS, INC. Director's Dealing 2021

Nov 8, 2021

34931_dirs_2021-11-08_67d658b5-4b5a-4d6d-9588-15c313cbfeb8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CALADRIUS BIOSCIENCES, INC. (CLBS)
CIK: 0000320017
Period of Report: 2021-06-17

Reporting Person: Girolamo Todd C (CLO, SVP of Corp Dev)